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Stlmrllsry 
To study the processes of thymic development, we have established transgenic mice expressing 
an or/3 T cell antigen receptor (TCK) specific for cytochrome c associated with class II major 
histocompatibility complex (MHC) molecules. The transgenic TCK chains are expressed by most 
of the thymocytes in these mice, and these cells have been shown to efficiently mature in association 
with E L and Ab-encoded class II MHC molecules.  This report describes a characterization of 
the negative selection of these transgenic thymocytes in vivo that is associated with the expression 
of A s molecules.  Negative selection by A s molecules appears to result in the deletion of a late 
stage of CD4/CD8 double-positive thymocytes in that there is a virtual absence of transgenic 
TCK bearing CD4 single-positive thymocytes. This phenotype is accompanied by the appearance 
of CD4/CD8 double-negative thymocytes and peripheral T cells that are functionally antigen 
reactive. The process of negative selection has also been investigated using an in vitro culture 
system. Upon presentation of cytochrome c by Eb-expressing nonthymic antigen-presenting cells, 
there occurs an antigen dose-dependent deletion of the majority of CD4/CD8 double-positive 
thymocytes. In contrast, presentation of Staphylococcal enterotoxin A by E  b in vitro results in 
minimal deletion of double-positive thymocytes. In addition, we use this in vitro model to examine 
the effects of cyclosporin A on negative selection.  In contrast to its effects on mature T  cells, 
and the findings of others in vivo, cyclosporin A does not inhibit antigen-induced deletion of 
double-positive thymocytes. Finally, a comparison of the antigen dose responses for thymocyte 
deletion and for peripheral T cell activation indicates that double-positive thymocyte recognition 
is more sensitive than mature T  cells to antigen recognition. 
T 
he establishment of immunological self-recognition and 
tolerance is known to occur primarily in the thymus, 
where thymocytes undergo a program of differentiation leading 
to  mature functional T  cells. Thymocytes are  specifically 
selected based on the specificity of their ot/B  TCR.  Most 
of the information currently available relates to the results 
of thymic selection  and not the selection process itself (1); 
the actual mechanism for selection has yet to be elucidated. 
T cells that survive thymic selection and are exported to the 
peripheral lymphoid organs are not overtly self-reactive, yet 
have the ability to recognize foreign antigenic peptides bound 
to MHC molecules that are also expressed in the thymus. 
The selection events that lead to a naive population of T cells 
specific for foreign peptides bound to self and not foreign 
alleles of the MHC molecules are termed positive selection; 
the deletion of T  cells overtly reactive to self-MHC mole- 
cules, presumably containing self-peptides,  is termed nega- 
tive selection (2). The distinction between the recognition 
events that lead to positive selection versus negative selection 
is not understood. 
The developmental pathway followed by thymocytes can 
be characterized by the expression of the TCR and the CD4 
and CD8 molecules. The earliest  T  cell precursors  in the 
thymus lack cell surface expression of these proteins (double 
negative;  DN), ~ and in a regulated sequence  that includes 
a productive rearrangement of the 3 chain and ot chain TCR 
genes, these precursor cells express CD4 and CD8 molecules 
(double positive; DP) and low levels of the TCR (3, 4). As 
shown using TCR transgenic mice, the further progression 
of these DP thymocytes to express high levels of the TCK 
and either the CD8 or CD4 molecules (single positive; SP) 
is dependent upon the TCR-mediated recognition of class 
I or class II MHC molecules, respectively, in the thymus (5-8). 
Experiments in normal animals using VB-specific antibodies 
have shown that the deletion of thymocytes reactive with 
self-encoded superantigens occurs within the transition from 
a DP to an SP cell (9-13). Results obtained with TCK trans- 
genic animals suggest that deletion can occur at earlier stages 
of differentiation depending upon the particular self-antigen 
1 Abbreviations  used in thispaper: CsA, cyclosporin  A; DN, double  negative; 
DE double  positive;  SEA, Staphylococcal  enterotoxin  A; SP, single  positive. 
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ence of the appropriate self-antigen in TCR. transgenic animals 
has been reported  to result in the absence of the majority 
of DP thymocytes in  some instances,  while in other cases 
clonal deletion appears to act upon cells only during the tran- 
sition from a DP to SP maturational  stage (7,  14-16).  Re- 
cently, it has also been shown that DP thymocytes in TCR 
transgenic animals can be induced to undergo programmed 
cell death upon administration of the specific antigenic pep- 
tide (17).  The stage at which physiological clonal deletion 
occurs is thus unresolved. 
In this report we describe the negative selection of thymo- 
cytes in cytochrome c/I-Ek-specific TCR transgenic  mice. 
Unexpectedly, in the presence of I-A  s, there is a block in the 
development of CD4 SP thymocytes and a variable decrease 
in the number of DP thymocytes. These mice also possess 
a high percentage ofDN thymocytes that express high levels 
of the transgene-encoded  TCR.  DN T  cells also appear in 
the peripheral  lymphoid organs of these mice,  and can be 
shown to be responsive to specific antigen. To better analyze 
the mechanisms involved in these processes, we have also de- 
veloped an in vitro culture system that appears to mimic many 
aspects of thymic clonal deletion.  We find antigen-specific 
and dose-dependent cell death of DP thymocytes induced by 
presentation of a peptide antigen by nonthymic antigen pre- 
senting  cells.  These results are discussed in relationship  to 
the requirements  for induction  of tolerance as well as the 
differentiation state and sensitivity of thymocyte subpopula- 
tions  to clonal deletion. 
Materials  and Methods 
Mice.  All mice were bred and maintained in the animal facility 
at the University  of California,  San Diego,  or Scripps Research 
Institute.  ce/B TCIk transgenic mice were originally generated as 
described previously (8). Inbred B10.A, B10.BIk, and B10.A(SR) 
mice were obtained from The Jackson Laboratory (Bar Harbor, ME). 
Cell Preparations.  4-8-wk-old mice were sacrificed by cervical 
dislocation, and single cell suspensions were obtained from thymus 
and lymph  node. 
Antibodies and Flow Cytometry.  PE-conjugated  anti-CD4  and 
FITC-conjugated  anti-CD8  rat  IgG mAbs  were obtained  from 
Becton Dickinson  & Co. (Mountain  View, CA). mAbs to TCR 
and B chains were KJ25 (anti-V/33; reference 18), 1F2 (anti-Vce11; 
reference 19) and tLR-8 (anti-Veal1; a generous gift from Dr. Osami 
Kanagawa, Washington University, St. Louis, MO). Unconjugated 
mAbs were detected by FITC-conjugated goat anti-hamster or goat 
anti-rat IgG (Caltag, South San Francisco, CA). Flow cytometric 
analysis was performed using a FACScan  |  flow cytometer (Becton 
Dickinson  & Co.) and FACScan  |  Research Software. 
T Cell Proliferation  Assay.  10  s transgenic T cells were cultured 
in 96-well microtiter  plates in the presence of 5  x  10  s irradiated 
spleen cells or confluent monolayers of irradiated FT16.6C5 mu- 
rine fibroblasts (generously provided by Dr. Ronald Germain, Na- 
tional Institute of Allergy and Infectious Diseases, Bethesda, MD) 
(20). Various concentrations  of pigeon  cytochrome  c,  88-104 
COOH-terminal  peptide,  moth cytochrome  c 88-103  COOH- 
terminal peptide,  or staphylococcal enterotoxin  A were included 
as indicated.  After 48 h,  the cultures  were pulsed with  I  /~Ci 
[3H]thymidine/well  (6.7  Ci/mmol;  DuPont  Co.,  Wilmington, 
DE) and harvested after an additional  16 h. 
IL2/IL,4 Assays.  10  s transgenic T calls were cultured  in 96- 
well microtiter plates in the presence of 5  x  l& irradiated spleen 
cells or confluent monohyers of irradiated FT16.6C5 murine fibro- 
blasts (as described above). Various concentrations  of moth cyto- 
chrome c 88-103 COOH-terminal peptide or staphylococcal en- 
terotoxin  A  were  included  as indicated.  After  48 h,  I1_,2/Ib4 
production was assayed by addition  of culture  supernatant  from 
the transgenic cell cultures to 104 NK cells, at a final concentra- 
tion of 20%. The NK cell cultures were then cultured for 24 h, 
pulsed with  1 #Ci [3H]thymidine/well  (6.7 Ci/mmol;  DuPont 
Co.) and harvested after an additional  16 h. 
In Vitro Thymocyte Antigen Culture.  Thymocytes were cultured 
in 24-well tissue culture  plates in RPMI (Irvine Scientific, Santa 
Ana,  CA) supplemented  with  10%  FCS (Gemini  Bioproducts, 
Calabasas, CA), antibiotics, t-glutamine,  and 5  x  10 -5 M 2-ME 
in the presence of a confluent monolayer of FT16.6C5 fibroblasts, 
and various concentrations of moth cytochrome c, 88-103 COOH- 
terminal peptide, or Staphylococcal enterotoxin  A (SEA), as indi- 
cated. Cells were cultured  21 h at 37~  in 5% CO2. Cells were 
then harvested by washing wells vigorously, the viable cells counted 
by trypan blue exclusion, and analyzed by flow cytometry. 
Results 
Induction  of Tolerance in  Transgenic Mice  That Express  A s. 
We have produced or//3 TCR transgenic mice using c~ and 
/3  chain  genes  that  encode a  receptor  specific  for  pigeon 
cytochrome c in association with I-E ~,S,b class II MHC mol- 
ecules (8,  20a).  The TCR expressed in these mice is com- 
posed ofoe and/3 chains derived from the cytochrome c-specific 
T  cell clones AN6.2 and 5C.C7, respectively (21, 22); this 
TCR is termed AND. Previous work with AND transgenic 
mice demonstrated positive selection of thymocytes mediated 
by the E k and, unexpectedly, A b molecules (8, 20a). Subse- 
quent analysis of mice bearing the H-2* MHC haplotype re- 
vealed a block in development of CD4 SP thymocytes.  As 
illustrated  in  Fig.  1 A,  thymuses  from  H-2  b/k haplotype 
AND transgenic mice can exhibit as many as 60% CD4 SP 
thymocytes. In contrast, thymuses from H-2  S/k AND trans- 
genic mice lack a significant CD4 SP population despite the 
presence of the E k molecules (Fig.  1 b). In addition to lack- 
ing  CD4  SP cells,  thymuses  from  H-2  */~ mice  contain  a 
higher percentage of CD4/CD8 DP ceils (45%) compared 
with thymuses from H-2  b/k AND transgenic  mice (28%). 
This phenotype suggests that thymocyte development to the 
CD4 SP stage is blocked at the CD4/CD8 DP stage or at 
the transition from the DP to the SP stage.  Since this lack 
of CD4 SP thymocyte development is seen in H-2  b/S mice 
(lacking surface I-E molecules), the block in maturation maps 
to  either  A S or  the  class  I  molecules  K S or  D s (data  not 
shown). The specificity of the AND receptor for class II MHC 
molecules suggests that the influence of the H-2  ' haplotype 
maps  to A S.  In  addition,  this reactivity is consistent with 
the  alloreactivity  to  A S seen  with  the  T  cell  clone  from 
which the B chain was derived (22). However, T  ceils from 
AND transgenic mice were tested for reactivity to B10.S or 
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Figure 1.  A' expression in the thymus results in a block in positive se- 
lection. Freshly removed thymocytes from H-2  b/a (.4, C, and E) vs. H-2  '/= 
(/3, D, and F) were  double  stained  with PE-conjugated  anti-CD4  and FITC- 
conjugated  anti-CD8 mAbs; and single stained  with anti-VB3 (KJ25) and 
anti-Vodl (1F2) mAbs as described  in Materials and Methods. Cells were 
subsequently analyzed  by flow cytometry.  (.4 and B) CD4/CD8 double 
staining. Numbers indicate  percent thymocytes  in each  quadrant. (C-F) 
V/33 and Vodl staining. Solid histogram  represents  VB3 and Vcdl staining; 
clear histogram  represents  staining  with FITC-conjugated  secondary  anti- 
body alone. 
B10.S(9R)  APCs bearing A', and no proliferation over back- 
ground was seen (data not shown). 
The distribution of thymocytes according to high vs. low 
TCR expression is distinctly different in H-2  b/' and H-2  '/' 
mice (Fig.  1, c-f). Two-color flow cytometry (anti-V33 vs. 
anti-CD4)  showed that thymocytes from H-2  b mice sepa- 
rated into two populations, a population that is V33-CD4 
dull, which represents the DP population,  and V/~3-CD4 
bright,  which  represents  with  the  CD4  SP  population. 
In contrast, in mice expressing A ~, there is no V/~3 bright/ 
CD4 bright thymocyte population. The CD4 bright thymo- 
cytes lack V33 expression, and conversely, the V33 bright 
cells are CD4  (and CDS)  negative (data not shown). 
The populations of T cells in the lymph nodes reflect the 
MHC-dependent differences in thymic selection seen in AND 
transgenic mice. In H-2  ' mice, the lymph nodes contain only 
20-50% CD3-positive cells, compared with 75-80% in the 
lymph nodes from H-2  b/~ mice (Table  1). In addition,  the 
T  cells that are present in A~-bearing  mice are composed, 
in part, of a large population ofCD4/CD8 DN cells, in some 
cases approaching 50%.  The size of the CD4 and CD8 SP 
populations vary considerably between individual mice; how- 
ever, there is a dramatic difference between the CD4/CD8 
ratios in mice expressing A' and those that do not. Whereas 
H-2  b/k mice have a large excess of CD4-positive cells,  the 
CD4/CD8 ratios in H-2' mice are similar to nontransgenic 
mice. Two-color flow cytometry analysis of the CD4-positive 
cells  in  H-2  '  mice  shows  that  there  are  very few V33- 
positive cells compared with H-2  b/k AND transgenic mice 
(9% compared with 77%, data not shown), and most of the 
V33-positive cells in H-2  '/k mice are DN.  In other experi- 
ments,  not presented here,  the DN  T  cells in H-2  ~ mice 
were tested for antigen reactivity. The results of these ex- 
periments showed dearly that  the DN,  V/83 +, Vall+  T 
cells were strongly reactive to pigeon cytochrome c presented 
on APCs from B10.A mice (data not shown). Taken together, 
these data indicate that the AND TCR expressed by thymo- 
cytes reacts with the I-A'-encoded class II molecule in such 
a way that a form of negative selection occurs. The net result 
is that AND TCR + , SP CD4 + cells appear to be missing 
from the thymus and peripheral lymphoid organs, whereas 
functional TCR +,  CD4-  thyrnocytes and spleen cells  are 
abundant. The interaction between the AND TCR and the 
I-A'-encoded ligand, especially in the absence of CD4, may 
be too weak to result in peripheral T  cell activation; thus, 
self-tolerance is  maintained  even  though  the  T  cells  are 
cytochrome c reactive. Alternatively, if deletion is dependent 
upon a sdf-peptide associated  with A% the ligand may only 
be expressed in the thymus. 
Deletion of Transgenic  DP Thymocytes in Tissue Culture.  To 
study the stages of thymocyte development that are sensitive 
to clonal deletion, the biochemical mechanism of clonal de- 
letion, and the efficacy of different ligands in the induction 
of these events,  a culture system that could mimic negative 
selection was developed. Previous studies demonstrated that 
the AND receptor recognizes moth cytochrome c in associa- 
tion  with  E b (20a).  We  therefore examined the effect of 
placing transgenic thymocytes in culture with antigen plus 
the murine L cell, FT16.6C5,  that was transfected with the 
gene encoding E ~ (20). The advantage of using the L cell 
transfectant over other sources of APCs was that they are 
a uniform population and easily distinguished from thymo- 
cytes in flow cytometry analyses by their size and granularity. 
Thymocytes from an H-2  b mouse were cultured in the pres- 
ence of various concentrations of moth cytochrome c 88-103 
COOH-terminal  peptide  and  a  confluent  monolayer  of 
FT16.6C5 cells. After 21 h of culture, the viable thymocytes 
were counted by trypan blue exclusion and analyzed by flow 
cytometry. Presentation of peptide  antigen by Eb-bearing 
APCs resulted in a dose-dependent and selective  depletion 
of DP thymocytes. Cell culture in the presence of 2.5, 0.25, 
and 0.025 #M moth cytochrome c peptide resulted, respec- 
tively, in 72, 55, and 22% reductions in percent DP thymo- 
cytes compared with the no antigen control (Fig.  2, a-d). 
1309  Vasquez  et al. Table  1.  Characterization  of Lymph Node Cells from AND  TCR  Transgenic  Mice 
Total  LN  Cells  CD3 +  Cells 
MHC  CD4/8 
Strain  H-2  molecules  Cell  #  Ig §  CD3 §  CD4  CD8  DN  Ratio 
x  10 -7  %  % 
AND  TG  b/a  A b/l~ E  b/k  2.0  12  87  94  3  3  31.3 
AND  TG  b/k  A b/a E  b/k  3.6  19  77  100  <1  <1  >100 
AND  TG  b/d  A b/d E  b/d  3.0  21  75  96  4  <1  24.0 
AND TG  b/s  A b/'  0.4  50  43  44  28  28  1.6 
AND TG  s/s  A'  1.9  68  23  43  12  45  3.6 
AND  TG  b/s  A b/'  2.6  69  28  34  22  44  1.5 
AND TG  a/s  A k/'  E  k/'  0.6  50  48  22  32  46  0.7 
Littermate  b/s  A b/'  3.0  10  87  63  37  <1  1.7 
Littermate  s/s  A ~/~  0.9  10  87  70  30  <1  2.3 
Littermate  b/d  A b/d E  b/d  4.7  ND  75  63  37  <1  1.7 
Lymph node cells from various AND transgenic or normal littermate  mice were stained with goat  anti-mouse Ig, anti-CD3, or anti-CD4 and anti- 
CDS.  Ig + and CD3 + percentages  were determined  by subtraction  of background  staining  obtained  with FITC-conjugated  normal  rat  Ig,  using 
FACScan |  Research  Software.  This  control  was  also  used  to  set  gates  for  determining positive  staining.  Percentages  of total  cells  that  were 
CD4+CD8 -  and CD4-CD8 + were determined by quadrant analysis as shown in Fig. 1, and then calculated as a percent of CD3 + cells. CD4+CD8 + 
cells were <0.5% of total.  CD4-CD8-  cells were calculated as all remaining CD3 + cells that were neither CD4 + nor CD8 + (CD4  =  CD4+CD8 - ; 
CD8  =  CD4- CD8 +  ; DN  =  CD4- CD8-  cells). 
These results were reproduced in nine separate experiments. 
Cell loss was not merely due to adherence of DP thymocytes 
to the fibroblast  APCs, as thymocyte/APC aggregation was 
not apparent by microscopic examination of harvested cells. 
In addition, flow cytometric analysis demonstrated that the 
APCs (characterized  by their forward light scatter pattern) 
were negative for the thymocyte markers CD4,  CD8,  and 
V/~3, thus indicating the absence of adherent thymocytes (data 
not  shown). 
While analysis of thymocyte subpopulations indicates  an 
antigen-dependent loss of DP thymocytes, it is important to 
note that the antigen culture system results  in a significant 
overall cell loss. Thymocyte recovery after overnight culture 
can range from 20 to 50%  even in the absence  of antigen. 
Analyses of the various subpopulations indicate this gross cell 
loss is nonspecific. In addition, the culture of nontransgenic 
thymocytes under these conditions resulted in similar overall 
cell losses,  indicating this result  is not unique to the trans- 
genic mice (data not shown). In light of this, thymocyte sub- 
population  sizes were monitored in all experiments  in the 
event that the decrease in percent DP cells was merely a reflec- 
tion of expansion or selective maintenance  of other subpopu- 
lations, particularly  the more mature CD4 SP or DN cells, 
in response to antigen. The actual number of cells recovered 
in the experiment presented in Fig. 2 are listed Table 2. These 
data demonstrate that loss of DPs, seen in terms of percent, 
is a reflection of actual cell loss. At 2.5/aM moth cytochrome 
c peptide, there is an 80% loss of DP thymocytes compared 
with  control  cultures.  Examination  of the  CD4  SP  and 
CD4/CD8 DN populations reveals that the DP cells are not 
converted to either of these other populations. 
Negative sdection of thymocytes may predominantly occur 
via a mechanism of programmed cell death, or apoptosis (17, 
23-25).  One characteristic  of apoptosis is a requirement for 
active  transcription and translation.  It is therefore possible 
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Figure 2.  Culturing with antigen results in loss of CD4/CD8 DP trans- 
genie thymocytes.  4  x  106 thymocytes  from an H-2  b mouse were cul- 
tured in the presence of FT16.6C5,  Eb-transfected fibroblasts, and various 
concentrations  of moth cytochrome  c, 88-103 COOH-terminal peptide 
as described in Materials and Methods.  Cells were harvested after a 21-h 
culture, counted, and analyzed for CD4 and CD8 surface expression by 
flow cytometry.  Numbers represent percent  of cells in each quadrant. 
1310  Induction of Clonal Deletion Table  2.  Deletion of CD4+8 §  Thymocytes Induced by Antigen  Presentation 
Total cells 
Moth cytochrome c  Cyclohexamide  recovered  CD4  CD8  DP  DN 
/~M 
0  -  15  12  0.1  2.6  0.6 
0.025  -  23  19  0.2  3.3  0.9 
0.25  -  9.4  8.1  0.1  0.7  0.5 
2.5  -  11  9.4  0.5  0.1  0.5 
0  +  18  13  0.1  4  0.7 
0.025  +  19  13  0.5  4  0.8 
0.25  +  18  13  0.2  4  0.8 
2.5  +  21  15  0.2  5  0.9 
After a 21-h culture with various concentrations of antigen (as described in Fig. 5 and Materials and Methods), cells were harvested, and viable 
cells counted by trypan blue exclusion. The subpopulation sizes were calculated based on overall cell recoveries, and CD4 and CD8 profiles were 
generated by two-color flow cytometry. The size of the populations are listed multiplied by 10-5 (CD4  =  CD4 +  CD8-; CD8  =  CD4-CD8 +; 
DP  =  CD4+CD8 + cells; DN  =  CD4-CDS-  cells). Cyclohexamide was added where indicated at 50/zg/ml. 
under some circumstances to block the induction of apop- 
tosis with pharmacological agents such as actinomycin D  and 
cyclohexamide (25). To determine whether or not the dele- 
tion seen in vitro had characteristics of an active cell death, 
we examined the effects of cyclohexamide on thymocytes cul- 
tured in the presence of antigen. Addition of this drug resulted 
in a complete inhibition of antigen-induced deletion (Table 
2). We have also examined the effect of addition of actinomycin 
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Figure 3.  Culturing with antigen results  in loss of CD4/CD8 DP thymo- 
cytes from an H-2  '/a mouse. 3  x  106 cells were cultured, harvested, and 
analyzed, as described in Materials and Methods. CD4 and CD8 surface 
profiles are shown after a 21-h culture in the presence of FT16.6C5 cells 
and various  concentrations  on moth cytochrome  c, 88--103 COOH-terminal 
peptide. Numbers represent percent of cells in each quadrant. 
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D  to cultures, and found that it is equally effective in blocking 
the death  of DP thymocytes (data not  shown). 
Transgenic mice expressing A s retain a large number  of 
DP cells in the thymus. It was of interest to determine whether 
these  thymocytes were  sensitive  to  negative  selection,  or 
whether they were past the maturational point where clonal 
deletion could  occur.  As  was  seen with  thymocytes from 
H-2  b mice, DP cells from H-2  '/a thymuses delete in a dose- 
dependent manner. Presentation of 2.5, 0.25, and 0.025/aM 
moth  cytochrome  c  peptide  resulted  in  65,  49,  and  5% 
decreases in the percent DP thymocytes, respectively, com- 
pared with the no antigen control (Fig. 3, a-d). Analysis of 
subpopulation  sizes confirmed the selective deletion of the 
CD4/CD8  DP  thymocytes. 
Because of the large populations of mature CD4-positive 
thymocytes in these in vitro cultures, the possibility remained 
that  the loss of DP cells was a nonspecific bystander effect 
caused by activation of mature thymocytes with antigen. For 
example, activation of CD4 SPs could result in the secretion 
of lymphokines at levels that induce nonspecific death of im- 
mature thymocytes under in vitro culture conditions. To ad- 
dress this issue, cocuhure experiments were carried out with 
thymocytes from a nontransgenic mouse and those from an 
H-2  ~/k transgenic mouse. Presentation of peptide antigen to 
transgenic thymocytes alone resulted in a 57%  decrease in 
absolute numbers of DP cells and had no significant effect 
on the CD4 or CD8 SP and DN cell subpopulations (Table 
3). As expected, the addition of pigeon cytochrome c to non- 
transgenic thymocytes cultured with fibroblast APCs had no 
specific effect on the viability of any of the subpopulations. 
Transgenic thymocytes were mixed with an equal number 
of nontransgenic thymocytes, and the effect of antigen cocul- 
ture was examined. The mixed cultures were designed to be 
skewed towards transgenic CD4 SP cells and nontransgenic 
DP cells. Based on subpopulation sizes seen with the unmixed 
populations, the ratio of CD4 SP thymocytes would be 5:1, Table  3.  Lack of Bystander Deletion 
-  Ag  + Ag 
Transgenic  Nontransgenic 
thymocytes  thymocytes  CD4  CD8  DP  DN  CD4  CD8  DP  DN 
+  -  77  4  11  8  83  3  5  8 
-  +  14  6  74  6  13  6  76  5 
+  +  49  4  40  7  49  5  40  6 
Cells were cultured and analyzed as described in Materials and Methods with or without antigen (2.5 mM moth cytochrome c, 88-103 peptide). 
After 21 h, cells were harvested and double stained for CD4 and CD8. Transgenic thymocytes were from an H-2  b/k mouse, and nontransgenic thymo- 
cytes were taken from a B10.A mouse. The third line represents an equal mixture of H-2  b/k transgenic thymocytes and B10.A thymocytes. The 
numbers indicate the percentage of cells in each subset (CD4 = CD4 +CDS- ; CD8  =  CD4- CD8 +  ; DP = CD4 +  CD8 + cells; DN  = CD4- CD8- 
cells). 
transgenic/nontransgenic and the DP thymocytes would be 
present at a ratio of 1:7, transgenic/nontransgenic.  In these 
mixed  cultures  there was  no  evidence for deletion  of DP 
thymocytes upon presentation of antigen despite the pres- 
ence of a significant population of cytochrome c-reactive CD4 
SP cells. These data indicate that deletion of DP thymocytes 
is the direct result of their recognition of the antigen/MHC 
ligand on the APCs, and not a bystander effect resulting from 
the  activation  of mature  CD4  SP cells. 
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Figure 4.  Comparison  of moth 
cytochrome c (88-103)/E  b dose 
responses  between  antigen-in- 
duced deletion ofDP thymocytes 
and  lymph  node  lymphocyte 
proliferation,  and  lymphokine 
production. (/t) Proliferation of 
lymph  node lymphocytes from 
H-2  b  AND  transgenic  mice. 
Results were generated  from three 
separate experiments,  and  the 
error bars represent the SD from 
the mean. Cells were cultured in 
the presence  of moth cytochrome 
c (88-103) and APCs as indicated, 
pulsed with [3H]thymidine, and 
harvested  (see Materials and 
Methods). Response is illustrated 
as percent of response generated 
by stimulation with 2.5 #g/ml 
Con A. (/3) Lymphokine  response 
from  H-2  b  AND  transgenic 
mice.  Lymphokine production 
was measured by monitoring the 
response of the II,2/IL-4-depen- 
dent NK cell line to culture su- 
pernatant from the transgenic  cell 
cultures￿9 Lymphokine responses 
to  cytochrome c  presented by 
B10.A(SR) vs. FT16.6C5 were ex- 
amined. Results are the average 
from two experiments and are plotted as percent of NK cell line response 
to 100 U/ml rlL2. (C) Percent loss of DP thymocytes  induced by antigen 
(conditions as indicated in the legend to Fig. 3). Results are an average 
of eight separate experiments  and are shown as percent loss compared  with 
control culture without antigen. 
Comparison of Thymocyte and Splenic T  Cell Sensitivity to 
Antigen.  To compare the antigen sensitivity of clonal dele- 
tion with that of T  cell activation, lymph node cells from 
H-2  b/a and H-2  b/b AND transgenic mice were cultured with 
APCs and various concentrations of moth cytochrome c frag- 
ment,  88-103 (Fig. 4 A).  The proliferative response of the 
lymphocyte cultures is presented as a percent of Con A  re- 
sponse, and plotted against the concentration of antigen added 
to culture.  A  comparison of dose-response curves between 
Eb-expressing APCs indicates that FT16.6C5 fibroblasts in- 
duce proliferation approximately fourfold less efficiently than 
B10.A(SR) splenocytes, as measured by the antigen dose re- 
quired to achieve 50%  of the Con A  response. 
Previous work has shown that some T  cell clones require 
IL-1 for proliferation, but not for lymphokine secretion (26), 
and thus a lack of cytokines, or accessory molecules expressed 
by the fibroblast-presenting cells, could account for the de- 
creased response. We reasoned that a measurement of lym- 
phokine production might be a more appropriate measure 
of T  cell activation. Fig. 4 B illustrates that transgenic lym- 
phocytes show a reduced proliferative dose response to moth 
cytochrome c and  FT16.6C5  fibroblasts,  but  they produce 
a significant lymphokine response. There is an apparent differ- 
ence  in  lymphokine  production  induced  by  antigen  plus 
FT16.6C5  cells vs.  splenocytes, and this  difference may be 
due to lymphokine depletion in the splenocyte cultures. These 
lymphocyte responses are particularly interesting when the 
dose-response curve for antigen-induced deletion ofDP thymo- 
cytes is considered (Fig. 4 C). Since the normalization values 
used for the proliferative responses and the lymphokine assays 
are relatively arbitrary and different from the way that dele- 
tion is calculated, it is difficult to directly compare the curves. 
However, there is an average of almost 30% thymocyte dele- 
tion at 0.025/zM peptide, whereas there is reproducibly little 
T cell proliferation or lymphokine secretion over background 
at  this  antigen  concentration.  This result  indicates  that  T 
cell activation is less sensitive to antigen than thymocyte de- 
letion. 
Examination of the Effects of Cyclosporin A  on Lymphocyte 
and  Thymocyte Cultures.  Cyclosporin  A  (CsA)  is  an  im- 
munosuppressant that appears to act by binding to cydophilin 
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AND transgenic  lymphocyte  pro- 
liferation  vs. DP thymocyte  dele- 
tion. (A) Lymph  node lympho- 
cytes from  H-2  b  AND transgenic 
mice were stimulated  with moth 
cytochrome  c 88-103 peptide  and 
B10.A(5R)  splenocytes in  the 
presence of 10 ng/ml  CsA as in- 
dicated. CsA control represents 
addition of equal amounts  in the 
CsA solvent. Results are the av- 
erage of two separate  experiments 
and are indicated  as percent  of  Con 
A response. (B) Transgenic  thymo- 
cytes were cultured with moth 
cytochrome  c 88-103 peptide  and 
FT16.6C5 fibroblasts. CsA and 
CsA control were  included  as in- 
dicated previously. Percent dele- 
tion ofDP thymocytes  was deter- 
mined as percent DPs compared 
with  control culture without 
antigen. 
and forming a complex that, in turn, binds to and poten- 
tially inhibits the activity of calcineurin/calmodulin (27).  It 
has been shown to inhibit T  cell proliferation, lymphokine 
secretion, and to interfere with thymic development both in 
vivo and in fetal thymic organ cultures (28-33).  Examina- 
tion of the mechanisms by which CsA interferes with T cell 
activation has demonstrated that the drug blocks the Ca  2  +- 
dependent activation of transcription  factors that are important 
to IL2 gene regulation (34, 35). We were therefore interested 
in the effects of CsA on transgenic lymphocyte proliferation 
and thymocyte  deletion. As expected, addition of CsA to lym- 
phocyte cultures completely inhibited proliferation induced 
by moth cytochrome c and B10.A(SR) splenic  APCs (Fig. 
5 A). We were surprised, however,  to find that addition of 
this drug under equivalent conditions had a relatively small 
effect on antigen-dependent deletion ofDP thymocytes (Fig. 
5 B). In the experiment presented, CsA was added at 10 ng/ml, 
and subsequent experiments showed that deletion was also 
insensitive to CsA at 100 ng/ml, 10-fold over the level needed 
for the inhibition of T cell activation. These results suggest 
that antigen-induced deletion of DP thymocytes is indepen- 
dent of the CsA-sensitive  intracellular events that are neces- 
sary for IL-2 secretion and T  cell proliferation. 
Examination of the Effects of SEA  on  Thymocyte and Lym- 
phocyte Antigen  Cultures.  SEA  is known to interact with 
TCRs expressing the VB3 gene element. This interaction has 
been shown to result in negative selection of V/33-bearing 
thymocytes in vivo,  and to induce proliferation of mature 
T  cells in vitro (36,  37).  It was therefore of interest to ex- 
amine the effects of SEA on lymphocyte and thymocyte cul- 
tures from AND transgenic mice. Stimulation of transgenic 
lymph node lymphocytes  with SEA and FT16.6C5 fibroblasts 
results in significant lymphokine production at a range of 
antigen doses (Fig. 6 A). In contrast, antigen-induced dele- 
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Figure  6.  Effect of SEA  on 
AND transgenic  lymphocytes  vs. 
thymocytes. (A)  Lymph node 
lymphocytes from H-2  b AND 
transgenic mice were stimulated 
with SEA or moth cytochrome  c 
88-103 peptide, and FT16.6C5 
fibroblasts. The cultures  were as- 
sayed  for lymphokine  production 
by monitoring  the response  of the 
IL-2/II:4-dependent  NK cell line 
to supernatants from the trans- 
genic cell cultures (see Materials 
and Methods). Results  are shown 
as percent  of  response  to 100 U/ml 
rlL2. (B) Transgenic  thymocytes 
were cultured with  SEA  and 
FT16.6C5 fibroblasts.  Percent  de- 
letion of DP thymocytes  was de- 
termined  as percent  DPs compared 
with  control culture without 
antigen. 
tion of DP thymocytes by SEA and FT16.6C5 is only in- 
duced at the highest antigen dose (Fig.  6 B). Therefore, in 
contrast to the results seen using moth cytochrome c as an- 
tigen, presentation of SEA by FT16.6C5 cells stimulates lym- 
phokine secretion in mature T cells at doses that do not in- 
duce deletion of DP thymocytes. 
Discussion 
The Timing and Magnitude of  Negative Selection.  Negative 
selection in the thymus has been demonstrated using a va- 
riety of experimental models, and through this work it has 
been suggested that clonal deletion occurs at the CD4/CD8 
DP stage of thymic development. Based on the size of the 
thymus and steady state populations present under different 
conditions, clonal deletion would appear to take place during 
a large portion of the DP differentiation state depending upon 
the/igand or receptor mediating the event (6, 9-13, 17, 38). 
However, the suggestion was made that the early deletion 
seen in transgenic mice could be due to the premature ex- 
pression of the TCR during thymocyte development (16), 
and that  superantigen-mediated deletion, characterized by 
using V/3-specific  antibodies,  was  the  more  physiological 
model. We have found that the phenotype of  mice transgenic 
for a particular c~//3 TCR specific for cytochrome c and class 
II MHC (8) may suggest an alternative view. The presence 
of the class II MHC-encoded molecule A' in these mice ap- 
parently prevents  the maturation of DP thymocytes to CD4 
SP thymocytes. Because it is genetically dominant over posi- 
tive selection mediated by A b or E  k, this effect is most likely 
a form of negative selection.  The deletion appears to occur 
late in DP thymocyte  development, as indicated by a significant 
proportion of DP cells in the thymus. This pattern of nega- 
tive selection in a transgenic mouse is thus similar to that 
seen with deletion of V/~17a-expressing  thymocytes by the 
I-E-encoded class II molecule (9),  V~6 and V~8.1 by Mls- 
1  ~ (10), and  VB3  by Mls-2  ~ (18); in  these  nontransgenic 
mice, immature DP thymocytes  bearing a self-reactive  receptor 
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similarity of the transgenic model presented here to the su- 
perantigen models is probably due to the fact that reactivity 
of the AND TCR with the A s ligand is very weak. There 
is no detectable stimulation of T  cells from H-2  ~/b AND 
transgenic mice with APCs from either B10.S or B10.S(9R) 
mice (data not shown). A more avid interaction of thymo- 
cytes and an antigen/MHC complex is likely to induce dele- 
tion at early DP stages (2, 17), perhaps regardless of whether 
the mouse expresses TCtL transgenes. A difference between 
antigen and superantigen deletion was previously described 
using a transgenic mouse bearing a receptor specific for lym- 
phocytic choriomeningitis virus (LCMV) and class I MHC, 
as well as Mls-1 ~ (14).  In this study, Pitcher et al. demon- 
strated  that  deletion of transgenic  thymocytes by Mls-1 a 
affected mature thymocytes  but not immature DP cells. How- 
ever, these same transgenic mice showed drastically depleted 
populations of both mature and immature thymocytes when 
LCMV and appropriate MHC were expressed. Whereas an- 
tigens can cause deletion to various levels and at various stages 
of DP maturation, perhaps superantigens can only cause de- 
letion of SP or transitional thymocytes. 
An even more dramatic distinction between antigen and 
superantigen deletion is seen using the in vitro culture system. 
Relative to the dose response for T  cell activation, SEA is 
extremely inefficient in causing the deletion of thymocytes, 
as demonstrated by the experiment presented in Fig. 6. This 
in contrast to the more comparable efficacy of moth cyto- 
chrome c in inducing T cell activation and thymocyte dele- 
tion. These data may relate to the differences between super- 
antigen and antigen/MHC binding to the TCR. For example, 
staphylococcal enterotoxin and Mls-1 '  have been shown to 
bind a region modeled to be on the side of the TCR mole- 
cule away from the proposed antigen/MHC binding site (39, 
40). In addition, differences have been seen in phosphoinosi- 
tide hydrolysis induced by an H-2 alloantigen and an Mls 
superantigen (41). An implication of these data, consistent 
with the CsA sensitivity discussed below, is that mature T 
cells and DP thymocytes are activated by different signaling 
pathways. This is revealed because the cellular activation events 
involving superantigens,  such as SEA,  and antigen/MHC 
ligands are in some way different. If these results can be ex- 
trapolated to all superantigens, then we would argue that 
the timing and magnitude of deletions caused by endoge- 
nous or exogenous superantigens may not be necessarily rep- 
resentative of the physiological negative selection and clonal 
deletion that occurs in response to self-antigens. 
The Mechanisms of Negative Selection.  An issue in thymic 
development is whether negative selection is determined by 
the function of specialized APCs or whether the determining 
factor is the stage of thymocyte development. For example, 
antigen presented on thymic macrophages could induce de- 
letion, whereas antigen presented on epithelial cells could in- 
duce further maturation. Alternatively, early DP thymocytes 
may interpret receptor ligation to result in positive selection, 
whereas later stage thymocytes may only be sensitive to nega- 
tive selection. We have demonstrated that DP thymocytes 
can be deleted by the presentation of specific antigen by non- 
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thymic APCs. Induction of negative selection thus may not 
be dependent upon the activity of specialized thymic APCs; 
however, an important caveat is that the required function, 
such as cell surface molecules or cytokines, may be present 
in FT16 fibroblasts.  Antigen added to culture can result in 
up to 80% loss in DP cells compared with thymocytes cul- 
tured in the absence of antigen, and deletion is dependent 
on tLNA and protein synthesis. It is therefore evident that 
the majority, but perhaps not all DP thymocytes, are sensi- 
tive to a TCR-mediated signal to undergo a programmed cell 
death. The magnitude of deletion appears  to be dependent 
on the avidity of the interaction, and this is implied by the 
antigen dose dependence of the deletion. Furthermore, anti- 
TCR antibodies have been reported to induce only 50% de- 
letion in fetal thymic organ cultures (42).  A recently pub- 
lished report using thymocytes from a TCR transgenic mouse 
specific for H-Y in association with H-2D b showed that DP 
cells are selectively depleted over a period of 24-48 h when 
cultured with male APCs (43).  Consistent with the results 
presented here, there was a population of thymocytes that 
were not deleted, even after 3 d in culture. Whether there 
exists  an early DP population that is wholly insensitive to 
deletion signals is presently unclear. We thus cannot presently 
distinguish between the above models of selection. 
A fundamental difference between in vitro antigen-induced 
clonal deletion and in vivo anti-TCR-induced clonal deletion 
is the sensitivity to CsA. Several reports indicate that CsA 
is effective in blocking clonal deletion induced in vivo by anti- 
TCR antibodies (29-31), whereas our experiments indicate 
that the direct, antigen-induced deletion of DP thymocytes 
is not sensitive to the effects of CsA at doses sufficient for 
complete inhibition of T cell activation (see Fig. 5). This ob- 
servation suggests that there are intracellular signaling events 
necessary for T  cell activation or anti-TCR-mediated dele- 
tion in vivo that are not required for antigen-induced thymo- 
cyte deletion. Studies have shown that CsA inhibits Ca  2§ 
dependent activation of transcription by NF-AT, NFIL-2A, 
NFII~2B, but does not effect Ca2+-dependent activation of 
c-Jos mKNA; this indicates that CsA blocks some, but not 
all,  Ca2+-dependent signaling pathways (44).  More recent 
data indicate that CsA works as a complex with cyclophilin 
A and inhibits the phosphatase calcineurin (27). Thus, it would 
appear that deletion of DP thymocytes does not depend on 
the release of free Ca  2  + in the same way as T cell activation, 
and more recent data indicate that it is highly dependent on 
the activation of protein kinase c  (N.  Vasquez  and S.  M. 
Hedrick,  unpublished  data).  We contend that  the results 
presented  here  more  directly  address  physiology  of  an- 
tigen/MHC-induced clonal deletion. Another set of studies 
by Mercep et al. (45) showed that a T cell hybridoma would 
undergo growth arrest and cell lysis when cultured in the 
presence of cytochrome  c and APCs. CsA did not affect growth 
arrest, but did affect IL-2 production and cell lysis. A conclu- 
sion of this study was that signals involved in growth arrest 
and activation diverge early in the course of the cellular re- 
sponse. The CsA-independent pathway may be analogous to 
that of thymocyte deletion presented here. 
The Sensitivity of  Clonal Deletion vs. T CelI Activation.  Several experiments now indicate that the process of clonal deletion 
is more sensitive to antigen  than  the process of mature T 
cell activation.  Using TCR transgenic  mice,  Pircher et al. 
(46) identified an antigen that could cause negative selection 
in vivo, but not activation of mature T cells in culture. Simi- 
larly, in the experiments presented here, we have shown that 
the  presence  of A s in  the  AND  transgenic  mice causes  a 
form of negative selection, yet thymic or splenic APCs bearing 
A s do  not  activate  CD4 +  mature  T  cells  from  AND-tg 
H-2  b/k mice.  Our results inducing  clonal deletion in vitro 
directly demonstrate this increased sensitivity of thymocytes 
vs. T  cells. As demonstrated in Fig. 4, there is a significant 
deletion of DP thymocytes at 0.025 #M 88-103 moth pep- 
tide, whereas virtually no T cell activation is detected at this 
antigen dose. Thus, although DP thymocytes express fewer 
receptors than mature T cells, in TCR transgenic and normal 
mice,  they appear to be functionally more sensitive to an- 
tigen.  We would speculate that  this differential sensitivity 
might result from the different second messengers involved 
in the two processes. It may have evolved in order to provide 
a margin  of safety to insure that  the population of T  cells 
will not respond to self-antigens encountered in the periph- 
eral  lymphoid organs. 
In conclusion, negative selection appears to be dependent 
on the affinity/avidity of the TCR and its ligand. Our results 
suggest that thymocytes are more sensitive to receptor liga- 
tion than are mature T  cells,  and that  this increased sensi- 
tivity may be mediated by a differential signaling pathway 
used by immature thymocytes. This hypothesis is addition- 
ally attractive because it provides a possible safeguard against 
autoreactivity. It should be noted that although clonal dele- 
tion is easily demonstrable in these cultures, we have found 
no evidence for the induction of positive selection in vitro. 
Cocultures of thymocytes with various preparations of thymic 
stromal cells, thymic stromal lines, or L cells expressing class 
II MHC do not appear to support the transition  from DP 
to  CD4 +  SP  thymocytes.  There  may  be  some  element 
missing  from  the  in  vitro  cultures  that  is present  in  the 
organismal  thymus, fetal thymus organ cultures, or deoxy- 
guanosine-treated  thymuses placed in organ culture (3, 4). 
Understanding the difference in signaling that distinguishes 
positive selection and negative selection is a major goal of 
future  studies. 
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